Journal
BIOCHEMISTRY AND CELL BIOLOGY
Volume 96, Issue 5, Pages 572-579Publisher
CANADIAN SCIENCE PUBLISHING
DOI: 10.1139/bcb-2017-0162
Keywords
aquaporin-5; colorectal cancer; 5-fluorouracil chemosensitivity; beta-catenin
Categories
Funding
- Special Clinical Foundation of Wujieping Medical Foundation Society [320.6750.1281]
- Liaoning Medical University [xzjj20140234]
Ask authors/readers for more resources
Aquaporin-5 (AQP5), a water channel protein, has been reported to possess oncogenic potential in multiple types of malignancies, including colorectal cancer (CRC). However, its effect on the chemosensitivity of CRC cells remains elusive. Hence, this study investigated the effect of AQP5 silencing in CRC cells on 5-fluorouracil (5-FU) sensitivity and attempted to elucidate the underlying mechanisms. A short hairpin RNA construct targeting AQP5 was transfected into HCT116 or HT29 cells to generate stable AQP5-silenced cell lines. The effects of AQP5 knockdown on cell viability, apoptosis, tumor growth, and 5-FU chemoresistance were evaluated. Relative protein levels of Wnt-beta-catenin pathway effectors were also measured. The results showed that silencing of AQP5 increased the chemosensitivity of CRC cells to 5-FU, facilitated 5-FU-mediated apoptosis, suppressed tumor growth, and reduced 5-FU chemoresistance in vivo. Furthermore, the effect of AQP5 on 5-FU chemosensitivity was mediated by the Wnt-beta-catenin pathway. Silencing of AQP5 inhibited Wnt-beta-catenin signaling, whereas overexpression of the degradation-resistant mutant of beta-catenin (S33Y) reversed apoptosis induced by AQP5 silencing. Taken together, these results suggest that AQP5 silencing enhances the sensitivity of CRC cells to 5-FU, and the underlying mechanism is related to inhibition of the Wnt-beta-catenin pathway. AQP5 could be a useful therapeutic target for CRC treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available